Survival and prognostic factors in bullous pemphigoid: A retrospective cohort study
Indian Journal of Dermatology, Venereology and Leprology · 2022
DOI: 10.25259/ijdvl_705_2021 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2022. Verfasst von Cristian Papara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, Germany. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Autoimmune Diseases, Skin Diseases, Vesiculobullous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Bullous pemphigoid is the most common subepidermal autoimmune blistering disease. Till now, the reported prognostic factors in bullous pemphigoid vary considerably.
Aims
The purpose of this study was to determine the overall survival rate and prognostic factors in bullous pemphigoid.
Methods
We conducted a retrospective cohort study on newly diagnosed bullous pemphigoid patients between July 2001 and November 2019 in a referral unit for autoimmune blistering skin diseases in Romania.
Results
One hundred forty-eight patients were included in the study. The Kaplan-Meier overall survival rates at 1, 3, 5 and 10 years were respectively 74.2% (95% confidence interval, 67.5-81.6%), 53.4% (45.7-62.2%), 43.6% (35.9-53%) and 31.3% (23.5-41.7%). The median follow-up among survivors was 48 months (interquartile range: 11-150). Ninety (60.8%) patients died during the follow-up period; of them, 38 (42.2%) had active disease at the time of death. Advanced age, neurological diseases, valvular heart disease, malignancies, use of statins, skin infections and extensive cutaneous involvement were linked to poorer outcomes, while the use of topical corticosteroids was associated with increased overall survival.
Limitations
This study lacks a control cohort to validate the obtained results. It was conducted in a retrospective manner in a single centre. In addition, indirect immunofluorescence microscopy was not performed in all patients.
Conclusion
Beyond ageing and neurological comorbidities, the prognosis of bullous pemphigoid patients was significantly influenced by the presence of skin infections, valvular heart disease, use of statins and extensive cutaneous involvement. Topical corticosteroid treatment was associated with increased survival in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, Germany.
- Department of Medical Informatics and Biostatistics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, Germany.
- Department of Centre for Biological Signaling Studies (BIOSS), University of Freiburg, Freiburg, Germany.
- Department of Dermatology, University of Lübeck, Lübeck, Germany.
Zitieren
APA
Papara, C., Chiorean, R., Leucuta, D. C., Baican, C., Danescu, S., Sitaru, C., Zillikens, D., & Baican, A. (2022). Survival and prognostic factors in bullous pemphigoid: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_705_2021
Vancouver
Papara C, Chiorean R, Leucuta DC, Baican C, Danescu S, Sitaru C, et al. Survival and prognostic factors in bullous pemphigoid: A retrospective cohort study. Indian Journal of Dermatology, Venereology and Leprology. 2022. doi:10.25259/ijdvl_705_2021
BibTeX
@article{Papara2022,
author = {Papara, Cristian and Chiorean, Roxana and Leucuta, Daniel-Corneliu and Baican, Corina and Danescu, Sorina and Sitaru, Cassian and Zillikens, Detlef and Baican, Adrian},
title = {Survival and prognostic factors in bullous pemphigoid: A retrospective cohort study},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2022},
doi = {10.25259/ijdvl_705_2021}
}
EUVIMED